Financial results - ADAMAPHARM S.R.L.

Financial Summary - Adamapharm S.r.l.
Unique identification code: 2800620
Registration number: J35/2120/1992
Nace: 4773
Sales - Ron
1.271.014
Net Profit - Ron
56.190
Employees
10
Open Account
Company Adamapharm S.r.l. with Fiscal Code 2800620 recorded a turnover of 2024 of 1.271.014, with a net profit of 56.190 and having an average number of employees of 10. The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Adamapharm S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 374.466 399.853 595.063 826.599 832.274 935.986 1.034.626 1.207.776 1.301.053 1.271.014
Total Income - EUR 374.468 399.855 597.513 827.334 834.435 941.988 1.037.869 1.221.627 1.329.155 1.294.070
Total Expenses - EUR 383.345 386.315 613.895 792.498 788.428 888.687 971.348 1.167.678 1.257.667 1.229.279
Gross Profit/Loss - EUR -8.877 13.540 -16.383 34.836 46.006 53.301 66.521 53.949 71.487 64.791
Net Profit/Loss - EUR -8.877 11.360 -21.983 26.568 37.662 44.559 56.143 46.754 61.422 56.190
Employees 10 11 15 18 16 17 18 16 14 10
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -1.8%, from 1.301.053 euro in the year 2023, to 1.271.014 euro in 2024. The Net Profit decreased by -4.888 euro, from 61.422 euro in 2023, to 56.190 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Adamapharm S.r.l.

Rating financiar

Financial Rating -
ADAMAPHARM S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Adamapharm S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Adamapharm S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Adamapharm S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Adamapharm S.r.l. - CUI 2800620

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 0 0 0 0 0 0 25.911 18.903 11.778 4.685
Current Assets 146.396 140.966 221.908 276.569 254.514 337.651 405.165 488.766 493.086 548.786
Inventories 93.164 91.217 143.879 161.225 149.726 201.158 239.979 286.464 303.593 357.248
Receivables 44.524 23.450 64.689 96.195 73.375 98.709 113.826 137.033 141.343 83.370
Cash 8.708 26.299 13.340 19.149 31.413 37.785 51.360 65.270 48.149 108.167
Shareholders Funds 18.533 29.703 7.217 33.653 49.590 72.535 94.725 101.218 121.900 117.099
Social Capital 56 56 55 54 53 52 51 51 51 50
Debts 127.863 111.263 214.691 242.917 204.925 265.116 336.351 406.451 382.964 436.372
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 548.786 euro in 2024 which includes Inventories of 357.248 euro, Receivables of 83.370 euro and cash availability of 108.167 euro.
The company's Equity was valued at 117.099 euro, while total Liabilities amounted to 436.372 euro. Equity decreased by -4.120 euro, from 121.900 euro in 2023, to 117.099 in 2024.

Risk Reports Prices

Reviews - Adamapharm S.r.l.

Comments - Adamapharm S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.